- Key Insight: Learn why employers plan coverage cuts for GLP‑1 drugs in 2027.
- What’s at Stake: Rising premiums may force employers to redesign benefits and shift cost burdens.
- Forward Look: Expect stricter utilization controls and program‑based eligibility in employer plans by 2027.
- Source: Bullets generated by AI with editorial review
A growing number of U.S. employers are expected to drop coverage of GLP-1 drugs in 2027 amid concerns about rising healthcare costs, according to a new survey.
